I think it’s pretty clear that partnership or full takeover has...

I think it’s pretty clear that partnership or full takeover has been the strategy from the outset, and that the real question has been how to balance the time to add value to the product (especially regulatory approval) against the cost of doing so. My investment strategy with this stock has been to assume that the optimum value add is at the point of regulatory approval, and I have been prepared to ride the various capital raisings to that point. I think the engagement of an M&A expert anticipates the imminent need to structure a off-market partnership or full takeover deal. The contemporaneous announcement of research partnerships for FIH TAVR testing corroborates that, IMHO. As I said, the point at which maximum value add has been achieved for a partnership or takeover is coming faster than I had anticipated. This is purely my own speculation. DYOR.